1221593-82-3

Basic information

• Product Name: (S)-benzyl 5-(4-((Z)-N'-acetoxycarbamimidoyl)benzylamino)-5-oxo-4-((R)-4-phenyl-2-(phenylmethylsulfonamido)butanamido)pentanoate
• Synonyms: (S)-benzyl 5-(4-((Z)-N'-acetoxycarbamimidoyl)benzylamino)-5-oxo-4-((R)-4-phenyl-2-(phenylmethylsulfonamido)butanamido)pentanoate
• CAS NO: 1221593-82-3
• Molecular Weight: 741.865
• Mol File: 1221593-82-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: (S)-benzyl 5-(4-((Z)-N'-acetoxycarbamimidoyl)benzylamino)-5-oxo-4-((R)-4-phenyl-2-(phenylmethylsulfonamido)butanamido)pentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-benzyl 5-(4-((Z)-N'-acetoxycarbamimidoyl)benzylamino)-5-oxo-4-((R)-4-phenyl-2-(phenylmethylsulfonamido)butanamido)pentanoate(1221593-82-3)
• EPA Substance Registry System: (S)-benzyl 5-(4-((Z)-N'-acetoxycarbamimidoyl)benzylamino)-5-oxo-4-((R)-4-phenyl-2-(phenylmethylsulfonamido)butanamido)pentanoate(1221593-82-3)

Safety Data

• Hazardous Substances Data: 1221593-82-3(Hazardous Substances Data)

Upstream product

• 13574-13-5 Boc-Glu(OBzl)-OH 
• 1221593-80-1 (S)-4-tert-butoxycarbonylamino-4-(4-cyano-benzylcarbamoyl)-butyric acid benzyl ester 
• 296787-77-4 (R)-4-phenyl-2-phenylmethanesulfonylamino-butyric acid 
• 1221593-81-2 (S,Z)-benzyl 4-(tert-butoxycarbonylamino)-5-(4-(N'-hydroxycarbamimidoyl)benzylamino)-5-oxopentanoate 
• 82795-51-5 D-homophenylalanine 
• 1939-99-7 benzenesulfonyl chloride 
• 1221593-81-2 (S)-4-tert-butoxycarbonylamino-4-[4-(N-hydroxycarbamimidoyl)benzylcarbamoyl]butyric acid benzyl ester 
• 1345040-63-2 (S)-4-tert-butoxycarbonylamino-4-[ 4-(N-acetylhydroxycarbamimidoyl)-benzyl carbamoyl]-butyric acid benzyl ester 
• 1221593-81-2 (S)-4-tert-butoxycarbonylamino-4-[4-(N-hydroxycarbamimidoyl)-benzyl carbamoyl]-butyric acid benzyl ester 
• 15996-76-6 4-cyanobenzylamine hydrochloride 

Relevant articles and documents

Pharmaceutical compositions with attenuated release of phenolic opioids

Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise a phenolic opioid prodrug that provides enzymatically-controlled release of a phenolic opioid, and an enzyme inhibitor that interacts with th

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE HYDROMORPHONE PRODRUG

The embodiments provide Compound PC-5, [2-((S)-2-malonylamino-6-amino-hexanoyl amino)-ethyl]-ethyl-carbamic acid hydromorphone ester, or acceptable salts, solvates, and hydrates thereof. The present disclosure also provides pharmaceutical compositions, and their methods of use, where the pharmaceutical compositions comprise a prodrug, Compound PC-5, that provides enzymatically-controlled release of hydromorphone, and, optionally, a trypsin inhibitor that interacts with the enzyme that mediates the enzymatically-controlled release of hydromorphone from the prodrug so as to attenuate enzymatic cleavage of the prodrug.

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise an opioid prodrug that provides enzymatically-controlled release of an opioid, and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the opioid from the opioid prodrug so as to attenuate enzymatic cleavage of the opioid prodrug.